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Abstract: Exercise has beneficial effects on our health by stimulating metabolic activation of skeletal
muscle contraction. Caffeine is a powerful metabolic stimulant in the skeletal muscle that has ergogenic
effects, including enhanced muscle power output and endurance capacity. In the present study,
we aim to characterize the metabolic signatures of contracting muscles with or without caffeine
stimulation using liquid chromatography-mass spectrometry and capillary electrophoresis coupled to
mass spectrometry. Isolated rat epitrochlearis muscle was incubated in the presence or absence or of
3 mM caffeine for 30 min. Electrical stimulation (ES) was used to induce tetanic contractions during
the final 10 min of incubation. Principal component analysis and hierarchical clustering analysis
detected 184 distinct metabolites across three experimental groups—basal, ES, and ES with caffeine
(ES + C). Significance Analysis of Microarray identified a total of 50 metabolites with significant
changes in expression, and 23 metabolites significantly changed between the ES and ES + C groups.
Changes were observed in metabolite levels of various metabolic pathways, including the pentose
phosphate, nucleotide synthesis, β-oxidation, tricarboxylic acid cycle, and amino acid metabolism.
In particular, D-ribose 5-phosphate, IMP, O-acetylcarnitine, butyrylcarnitine, L-leucine, L-valine, and
L-aspartate levels were higher in the ES + C group than in the ES group. These metabolic alterations
induced by caffeine suggest that caffeine accelerates contraction-induced metabolic activations,
thereby contributing to muscle endurance performance and exercise benefits to our health.
Keywords: metabolome; skeletal muscle; exercise; muscle contraction; ergogenic effect
1. Introduction
Exercise contributes to health benefits by reducing the risk of several chronic diseases. These effects
are partly attributed to metabolic alterations that occur in contracting skeletal muscles. Exercise enhances
muscle insulin sensitivity and mitochondrial function by stimulating master metabolic regulators,
such as 5′-AMP-activated protein kinase (AMPK), sirtuin 1, and peroxisome proliferator-activated
receptor-γ co-activator 1α [1,2]. Recent evidence has suggested that secreted myokines from contracting
skeletal muscles have positive effects on metabolic disorders [3]. Therefore, it is accepted that muscle
contraction-induced metabolic activation is a key factor for maintaining normal physical function.
Caffeine is a powerful metabolic stimulant in the skeletal muscle. In vitro caffeine treatment of the
skeletal muscle promotes insulin-independent glucose transport [4–8], fatty acid oxidation [8,9], Ca2+
release from the sarcoplasmic reticulum [10,11], and mitochondrial biogenesis [12]. We have recently
demonstrated that caffeine increases the maximal capacity of contraction-stimulated AMPK activation
and glucose transport in rat skeletal muscles [6]. Additionally, caffeine is thought to be an important
contributor to ergogenic effects in humans. Meta-analyses have shown that caffeine intake has positive
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effects on muscle power output and endurance performance [13–15]. These findings suggest that
caffeine accelerates muscle contraction-induced metabolic activation, thereby contributing to exercise
benefits toward health promotion. However, there are no observations investigating the overall effects
of caffeine on muscle contraction-induced metabolic activation in the skeletal muscle.
Metabolomic techniques are useful tools for the investigation of complex metabolic responses
to muscle contraction [16,17]. In the present study, we aim to characterize the metabolic signatures
of contracting muscles with or without caffeine stimulation, using liquid chromatography-mass
spectrometry (LC-MS) and capillary electrophoresis coupled to mass spectrometry (CE-MS) analysis.
2. Materials and Methods
2.1. Animals
Male Sprague–Dawley rats (150–160 g) were purchased from Shimizu Breeding Laboratories
(Kyoto, Japan). Rats were fed a standard diet (Certified Diet MF; Oriental Koubo, Tokyo, Japan) with
ad libitum water and were subjected to overnight fasting before the experiments. All animal-related
protocols were performed in accordance with the Guide for the Care and Use of Laboratory Animals
as adopted and promulgated by the National Institutes of Health (Bethesda, MD, USA) and were
approved by the Animal Use Committee at Kyoto University Graduate School of Human and
Environmental Studies.
2.2. Muscle Treatment
Muscles were treated as previously described [6]. Rats were killed by cervical dislocation without
anesthesia, and the epitrochlearis muscles were removed and mounted on to an incubation apparatus
with the tension set to 0.5 g. The epitrochlearis muscle is composed predominantly of fast-twitch
glycolytic fibers (60–65% fast-twitch white, 20% fast-twitch red, 15% slow-twitch red) [18], but also has
higher oxidative potential than the other fast-twitch muscle [19]. Moreover, it is a small and thin muscle
that is suitable for in vitro incubation study. The muscles were pre-incubated in alpha-minimum
essential medium (21444-05, nacalai tesque, Kyoto, Japan) containing 1.0 g/L glucose supplemented
with 1% penicillin/streptomycin for 40 min and then incubated in fresh medium in the presence or
absence of 3 mM caffeine for 30 min. For tetanic contractions, the muscles were stimulated using an
electric stimulator (SEN-3401; Nihon Koden, Tokyo, Japan) during the final 10 min of the incubation
period (train rate, 1/min; train duration, 10 s; pulse rate, 100 Hz; pulse duration, 0.1 ms; voltage; 10 V).
Basal muscles were pre-incubated and incubated without contraction and caffeine treatment. All media
were continuously gassed with 95% O2/5% CO2 and maintained at 37 ◦C.
2.3. Metabolomic Analysis
Metabolomic analysis was performed by LSI Medience Corporation (Tokyo, Japan). In brief, the
muscle samples (≥50 mg) were homogenized using beads and suspended into 1 mL distilled water.
They were then mixed with methanol (2 mL) and chloroform (2 mL) for 10 min at room temperature.
After centrifugation at 1000× g for 15 min, the supernatant was evaporated using nitrogen gas and
dissolved with 10% acetonitrile aqueous solution (200 µL). After adding internal standards, the samples
were subjected to both LC-MS and CE-MS. All peak positions (retention time and m/z) and areas
were calculated using Markeranalysis (LSI Medience, Tokyo, Japan). All peak areas were aligned
into one data sheet, and the errors of peak intensities were corrected using internal standards. Noise
peaks were deleted after comparison with the peaks detected in blank samples. The metabolites were
identified by comparing the retention times and m/z values with a standard dataset provided by LSI
Medience Corporation.
2.4. Data Analysis
After applying autoscaling (mean-centered and divided by standard deviation of each variable),
principal component analysis (PCA), significance analysis of microarray (SAM), hierarchical clustering
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analysis (HCA), and one-way ANOVA with Tukey’s multiple comparison test were performed using
the web-based metabolomic data processing tool MetaboAnalyst 4.0 (http://www.metaboanalyst.ca,
Xia Lab, McGill University, Montreal, Canada). In PCA, a score plot of the first and second principal
components was generated. HCA was performed to exhibit simultaneous clustering of metabolites
and samples by Euclidean distance using Ward’s method. Heat maps were generated by coloring the
values of all data across their value ranges. False discovery rates (FDR) were calculated to reduce the
risk of false positives by adjusted p values. FDR < 0.05 was defined as statistically significant.
3. Results and Discussion
3.1. Pattern Recognition of Metabolites
Metabolomic analysis detected 184 metabolites by LC-MS and CE-MS (Table S1). PCA is a statistical
procedure that is used for feature extraction. Using PCA on the detected 184 metabolites, three groups,
i.e., basal, electrical stimulation (ES), and ES with caffeine (ES + C), were clearly distinguished on
the principal component (PC) 2, although they were overlapped on PC1 (Figure 1). We previously
demonstrated that ES in isolated rat skeletal muscles induces metabolic activation [20]. Likewise, the
PCA results in this study indicated that ES-induced muscle contraction influences the metabolomic
profile of the skeletal muscle. Furthermore, PCA plots in the ES + C group were more distant from basal
than in the ES group (Figure 1), suggesting that caffeine accelerates ES-induced metabolic responses.
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Figure 1. Principal component analysis (PCA) plot of the identified metabolites of the skeletal muscle of
three groups, basal (B), electrical stimulation (ES), and electrical stimulation + caffeine (ESC). Principal
components (PC1 and PC2) capture 53.0% of the variation in the d taset. The elliptic areas r present
the 95% confidence regions.
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3.2. Discovery of Differentiating Metabolites
To identify differentially expressed metabolites among the three groups, SAM, a popular method
employed in microarray data analysis [21], was used. SAM identified a total of 50 metabolites with
FDR = 0.007 (Figure 2). Table 1 lists the identified compounds. HCA of the 50 metabolites showed that
each group was tightly clustered and that the caffeine influenced the metabolite profiles of ES toward
a high level of contents (Figure 3). Figures 4–7 show the 23 metabolites that significantly changed
between the ES and ES + C groups.
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Table 1. Significant features identified by SAM.
Name d Value SD p Value q Value
1 Theobromine 5.7247 0.031023 0.0 0.0
2 Butyrylcarnitine (C4) 5.4855 0.055814 0.0 0.0
3 IMP 5.0676 0.10169 0.0 0.0
4 β-Aminoisobutyric acid 4.7254 0.14193 0.0 0.0
5 L-Lactic acid 4.6827 0.14713 0.0 0.0
6 Cytosine 4.4855 0.1717 5.4348 × 10−5 1.1445 × 10−4
7 D-Ribose 5-phosphate 4.4111 0.1812 5.4348 × 10−5 1.1445 × 10−4
8 D-Glyceraldehyde 4.3854 0.18452 5.4348 × 10−5 1.1445 × 10−4
9 Hypoxanthine 4.3489 0.18926 5.4348 × 10−5 1.1445 × 10−4
10 Maltotriose 4.2295 0.205 5.4348 × 10−5 1.1445 × 10−4
11 D-Glucosamine 6-phosphate 4.1269 0.21883 1.087 × 10−4 1.7607 × 10−4
12 Choline 4.1237 0.21927 1.087 × 10−4 1.7607 × 10−4
13 Succinic acid 4.0087 0.2351 1.087 × 10−4 1.7607 × 10−4
14 N4-Acetylcytidine 3.8995 0.25048 1.6304 × 10−4 2.4524 × 10−4
15 L-Glutamate 3.6907 0.28084 3.2609 × 10−4 4.2917 × 10−4
16 Acetylenedicarboxylate 3.6613 0.28523 3.2609 × 10−4 4.2917 × 10−4
17 L-Leucine 3.5719 0.29872 4.8913 × 10−4 5.7223 × 10−4
18 1-Myristoylglycerophosphocholine 3.5708 0.29889 4.8913 × 10−4 5.7223 × 10−4
19 L-Hexanoyl-carnitine (C6) 3.4897 0.31135 5.4348 × 10−4 6.0234 × 10−4
20 Serotonin 3.4538 0.31693 5.9783 × 10−4 6.2945 × 10−4
21 Threonate 3.4109 0.32367 7.0652 × 10−4 7.0847 × 10−4
22 Glycerol-3-phosphate 3.2018 0.35736 0.001413 0.0012937
23 2-Oxobutanoate 3.1997 0.35772 0.001413 0.0012937
24 ATP 3.009 0.38981 0.0021739 0.0018047
25 N-Acetyl-L-alanine 3.0039 0.3907 0.0021739 0.0018047
26 L-Alanine 2.9853 0.39391 0.0022283 0.0018047
27 Xanthine 2.9261 0.40421 0.0023913 0.001865
28 Imidazole lactic acid 2.913 0.40651 0.0025543 0.001921
29 N8-Acetylspermidine 2.8766 0.41292 0.002663 0.0019337
30 NADP 2.8527 0.41718 0.0029348 0.0020305
31 Oxypurinol 2.8504 0.41759 0.0029891 0.0020305
32 Taurine 2.7011 0.44464 0.0040761 0.0026823
33 O-Acetylcarnitine (C2) 2.6096 0.46169 0.0052174 0.0032651
34 Isatin 2.5882 0.46572 0.0052717 0.0032651
35 L-Fucose 2.5586 0.47133 0.0057065 0.0034334
36 Spermidine 2.5126 0.48016 0.0064674 0.0037831
37 1-Palmitoleoylglycerophosphocholine 2.4683 0.48872 0.0071739 0.0040357
38 GDP 2.4586 0.49062 0.0072826 0.0040357
39 Iminodiacetate 2.3301 0.51606 0.0096196 0.0051941
40 L-Methionine 2.3125 0.51962 0.010054 0.0052477
41 γ-Glu-leu 2.3104 0.52004 0.010217 0.0052477
42 Maleamate 2.2816 0.52587 0.010761 0.0052964
43 L-Aspartate 2.2673 0.52879 0.010815 0.0052964
44 Guanidinosuccinic acid 2.2214 0.53822 0.011793 0.0056442
45 L-Valine 2.169 0.54911 0.013478 0.0062447
46 CDP 2.1582 0.55136 0.013641 0.0062447
47 EDTA 2.134 0.55645 0.014511 0.0064614
48 2-Hydroxyisobutyric acid 2.126 0.55815 0.014728 0.0064614
49 Creatinine 2.1072 0.56212 0.015163 0.0065164
50 3-Methyl-2-oxobutyric acid 2.0385 0.57683 0.017065 0.0071872
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3.3. Pentose Phosphate Pathway/Nucleotide Synthesis Pathway
The pentose phosphate pathway is an alternative pathway to glycolysis [22]. It does not lead to ATP
formation, but rather, produces ribose 5-phosphate. Intracellular ribose 5-phosphate concentration is an
important determinant of rates of de novo purine synthesis [23]. The synthesis of purine nucleotides
begins with ribose 5-phosphate and produces the first fully formed nucleotide, IMP. IMP is accumulated
in contracted skeletal muscle during exercise and accounted for ATP re-synthesis during recovery
phase from exercise [24]. Therefore, pentose phosphate pathway activation and subsequent nucleotide
synthesis is suggested to be important for maintaining cellular energy during and following exercise.
In the present study, ES increased D-ribose 5-phophate levels, and caffeine further increased this
effect (Figure 4), indicating that caffeine promotes exercise-induced activation of the pentose phosphate
pathway in skeletal muscles. It was also found that caffeine in conjunction with ES increased IMP
levels, as compared to ES alone (Figure 4). Taken together, the stimulation of the pentose phosphate
pathway by caffeine may contribute to recovery from energy depletion following muscle contraction
by promoting ATP re-synthesis from IMP. In our previous study, caffeine alleviated muscle fatigue
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during contraction [6]. Furthermore, it has been suggested that activation of the pentose phosphate
pathway stimulates energy production by enhancing mitochondrial function [25]. These metabolic
responses may contribute to a positive effect of caffeine on endurance performance.
A small proportion of IMP is converted to inosine and further to hypoxanthine, and hypoxanthine
is transformed to xanthine, which is then subsequently converted to uric acid and excreted in the
urine [26]. In the present study, hypoxanthine and xanthine levels were increased by caffeine treatment
in the contracted muscle (Figure 4), supporting the caffeine-induced accumulation of IMP.
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3.4. Acylcarnitine/Tricarboxylic Acid (TCA) Cycle
Acylcarnitines, which are esters of L-carnitine and fatty acyl-coenzyme A (CoA), are important
intermediates in the transport of long-chain fatty acyl-CoA into the mitochondria [27]. Intramitochondrial
acylcarnitine is converted back to carnitine and long-chain acyl-CoA by carnitine palmitoyltransferase
2, which then undergoes β-oxidation to produce acetyl-CoA. Acetyl-CoA is an essential intermediate
metabolite that enters the TCA cycle and is oxidized to yield energy. When the production of
short-chain acyl-CoAs exceeds TCA cycle flux, acetyl-CoA is converted to acetylcarnitine by carnitine
acetyltransferase [28]. In the present study, caffeine treatment increased O-acetylcarnitine (C2) during
skeletal muscle contraction (Figure 5), indicating that substrate catabolism during β-oxidation exceeds
the capacity of acetyl-CoA utilization in the TCA cycle.
Muscle contraction-induced AMPK activation inhibits acetyl-CoA carboxylase activity, leading
to a decrease in malonyl CoA content [29]. Malonyl CoA is a potent inhibitor of CPT1, an enzyme
that combines fatty acyl-CoA with carnitine for transport into the mitochondria for β-oxidation, and
the decrease in malonyl CoA during muscle contraction contributes to the increase in absolute lipid
oxidation [30]. In addition, it has been demonstrated that the increase in acetylcarinitine level during
muscle contraction decreases the availability of free carnitine, a substrate of CPT1, results in low CPT1
activity [31]. Thus, the accumulation of acetylcarnitine within the skeletal muscle leads to a diminished
supply of long-chain fatty acyl-CoA to β-oxidation [31]. In fact, an increase in acetylcarnitine was
observed concomitantly with a decrease in long-chain fatty acid oxidation during exercise in humans [31].
In the present study, L-hexanoyl-carnitine (C6) was reduced by caffeine treatment (Figure 5), indicating
that the increase in muscle acetylcarnitine level by caffeine might inhibit β-oxidation of long-chain fatty
acyl-CoA, thereby leading to a decreased supply of short-chain (~C10) fatty acyl-CoA.
However, we found the accumulation of butyrylcarnitine (C4) following caffeine treatment
(Figure 5). In accordance with this result, a previous study has demonstrated that the 10 min of treadmill
exercise increased C4 acylcarnitine level in rat skeletal muscle [32]. The authors have suggested that
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the accumulation of C4 acylcarnitine was attributed to a greater utilization of branched chain amino
acids (BCAA: leucine, isoleucine, and valine) [32]. We also found that caffeine treatment increased
L-leucine and L-valine levels in contracted muscle (Figure 6). Therefore, it is suggested that the increase
in butyrylcarnitine (C4) level originates from the amino acids metabolism.
Succinic acid is a key TCA cycle metabolite, the levels of which can be increased by both long-term
exercise training as well as an individual bout of exercise [17,33]. In the present study, caffeine increased
succinic acid levels in the contracted muscle (Figure 5). This result suggests that the TCA cycle is
activated by caffeine treatment during muscle contraction. However, succinic acid level is reflected
by the activity of succinate dehydrogenase, which catalyze succinic acid into fumarate in the TCA
cycle. Therefore, to determine the effect of caffeine on the activity level of the TCA cycle during muscle
contraction, succinate dehydrogenase level and/or another enzyme activity and metabolite levels need
to be investigated.
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In the present study, glycolysis was not affected by caffeine (Figure 8), suggesting that an increase
in acetylcarnitine following caffeine treatment can be attributed to the acceleration of acetyl-CoA
production from β-oxidation. Maintaining the acetylcarnitine recycling system is critical for muscle
contractile performance and fatigue resistance [34]. Therefore, caffeine may stimulate the acetylcarnitine
recycling system, thereby contributing to enhanced muscle endurance capacity. To assess this possibility,
further study is required to measure the effects of caffeine on carnitine.
3.5. Amino Acid/Amino Acid Metabolism
Protein degradation and subsequent amino acid oxidation contribute slightly to energy supply
during exercise as well as to glucose and fatty acid oxidation [35]. Six amino acids are metabolized in
the skeletal muscle: BCAA (leucine, isoleucine, and valine), asparagine, aspartate, and glutamate [35].
Leucine can be converted to acetyl-CoA and oxidized in the TCA cycle [36]. The catabolic pathway of
valine consists of several enzymatic steps and results in the formation of succinyl-CoA, a member of the
TCA cycle. Disruption of BCAA metabolism in skeletal muscle impairs endurance capacity [37]. Thus,
the supply of BCAA is considered to be an important factor for control ing exercise me olism and
endurance. In the present study, L-leucine and L-valine were higher in the ES + C group than in the ES
group (Figure 6), indicating that these amino acids contribute to energy production of caffeine-treated
muscle by incorporated into TCA intermediates.
Aspartate has been suggested to have an ergogenic potential [38]. Aspartate is converted to
oxaloacetate by aspartate transaminase, which then enters the TCA cycle. A previous study has
demonstrated that the administration of potassium-magnesium-aspartate increased the capacity for
prol nged exercise in human [39]. This effect has b en supported by other studies [38]. In the present
study, caffeine suppressed L-aspartate reduction by ES (Figure 6), indicating that the caffeine-induced
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ergogenic effect may be partly attributed to aspartate preservation during muscle contraction. However,
there are a number of negative findings related to aspartate’s ergogenic potential [38]. For example, in
human volunteers neither the exerted force nor the endurance time increased after oral administration of
potassium-magnesium-aspartate [40]. Therefore, further studies are required to clarify the relationship
between aspartate and caffeine’s ergogenic potential.
Methionine is suggested to be transaminated and is also subjected to transulfuration in the skeletal
muscle [41]. Although caffeine increased L-methionine levels (Figure 6) in the contracted muscle, the
importance of methionine during exercise is poorly understood.
Alanine is formed from pyruvate and glutamate in the alanine aminotransferase reaction. Increase
in skeletal muscle alanine is thought to be due to the enhanced availability of pyruvate and glutamate [42].
Alanine synthesized in the skeletal muscle is released into the blood and taken up by the liver, where it
is reconverted into glucose via gluconeogenesis. In the present study, caffeine treatment increased
L-alanine during muscle contraction (Figure 6). Considering that pyruvate and glutamate were
not changed by caffeine stimulation (Table S1), this caffeine-induced increase in alanine may be
attributed to protein degradation. The increase in alanine production may contribute to the increase in
N-acetyl-L-alanine levels, which is generated from alanine by phenylalanine N-acetyltransferase, in
caffeine and electrically stimulated muscle (Figure 6).
Nutrients 2019, 11, x FOR PEER REVIEW 9 of 14 
 
administration of potassium-magnesium-aspartate [40]. Therefore, further studies are required to 
clarify the relationship between aspartate and caffeine’s ergogenic potential. 
Methionine is suggested to be transaminated and is also subjected to transulfuration in the 
skeletal muscle [41]. Although caffeine increased L-methionine levels (Figure 6) in the contracted 
muscle, the importance of methionine during exercise is poorly understood. 
Alanine is formed from pyruvate and glutamate in the alanine aminotransferase reaction. 
Increase in skeletal muscle alanine is thought to be due to the enhanced availability of pyruvate and 
glutamate [42]. Alanine synthesized in the skeletal muscle is released into the blood and taken up by 
the liver, where it is reconverted into glucose via gluconeogenesis. In the present study, caffeine 
treatment increased L-alanine during muscle contraction (Figure 6). Considering that pyruvate and 
glutamate were not changed by caffeine stimulation (Tabl  S1), this caffeine-induced increase in 
alanine may be at r but d to pr tein degradation. The inc ease in alanine prod cti n may contr bute 
to the increase in N-acetyl-L-alan ne levels, which is generated from alanine by phe ylal nine N-
acetyltransferas , in caffeine and electri ally stimulated muscle (Figure 6). 
Figure 6. Box plots of the concentration variations of significantly altered metabolites in the amino 
acid/amino acid metabolism. * One-way ANOVA with Tukey’s post hoc test indicates a significant 
difference (FDR < 0.05) between groups. 
3.6. Others 
N4-acetylcytidine, choline, cytosine, 2-hydroxyisobutyric acid, isatin, guanidinosuccinic acid, 
oxypurinol, ethylenediaminetetraacetic acid (EDTA), and acetylenedicarboxylate levels were 
significantly higher in the ES + C group than in the ES group (Figure 7). However, no previous studies 
have investigated the association between exercise and these metabolites. The functional significance 
of increased levels of these metabolites in the caffeine-stimulated group needs to be further 
investigated. 
Figure 6. Box plots of the concentration variations of significantly altered metabolites in the amino
acid/amino acid metabolism. * One-way ANOVA with Tukey’s post hoc test indicates a significant
difference (FDR < 0.05) between groups.
3.6. Others
N4-acetylcytidine, choline, cytosine, 2-hydroxyisobutyric acid, isatin, guanidinosuccinic acid,
oxypurinol, ethylenediaminetetraacetic acid (EDTA), and acetylenedicarboxylate levels were significantly
higher in the ES + C group than in the ES group (Figure 7). However, no previous studies have investigated
the association between exercise and these metabolites. The functional significance of inc ased levels
of thes metaboli es in the caffeine-stimulated group eeds to be further investigated.
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3.7. Limitations
Many reactions take place continuously within cells, so concentrations of metabolites are very
dynamic. In the present study, we investigated metabolomic responses only 10 min after muscle
contraction. Therefore, in a case where increased levels of metabolites are bserved, two distinct
mechanisms contribute to this observation: either increased production or decreased consumption.
For further understanding of caffeine-mediated effects on metabolic changes during muscle contraction,
time-course experiments should be conducted.
In this study, we used a concentration of caffeine at 3 mM, which would be toxic to humans [43].
Plasma concentration of caffeine after ingestion of 100 mg (1 cup of coffee) reaches approximately 5
to 10 µM [44], with less than 70 µM being the physiological concentrations [45]. Experiments using
isolated skeletal muscle preparation have benefits of eliminating the effects of systemic confounders
such as circulatory, humoral and neural factors, and of intestinal absorption of caffeine. Taking
advantage of this point, a number of studies have unveiled the direct rgogenic properties of caff ine
at the upraphysiological concentrations [10,46–49]. Our previous study have demonstrated that µM
concentrations were enough to ctivate AMPK in vivo, but mM concentrations f caffeine were needed
to activate AMPK in isolate rat skeletal muscle [5]. Therefore, we should be careful when comparing the
results of in vitro and in vivo studies in terms of caffeine concentrations.
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Caffeine is found in foods, beverages, and pharmaceuticals, and the most frequently consumed
non-prescription drug. To date, many researchers have discussed the effect of caffeine on energy
metabolism and our health [50–52]. However, no study has investigated the caffeine-mediated changes
of metabolomic signatures in skeletal muscle and the other organs. Although the present study
contributes to unveiling the effect of caffeine on metabolomic responses during muscle contraction
condition, the effect of caffeine alone on skeletal muscle metabolism has not been cleared. Further
studies are expected to examine the effect of caffeine on muscle’s non-contracted condition.
4. Conclusions
The present study reveals for the first time that caffeine influences metabolic responses induced by
electrically stimulated muscle contraction in isolated rat skeletal muscles. A schematic representation of
the metabolic changes induced by caffeine is shown in Figure 8. Many of these changes are related to
energy metabolism. First, caffeine promotes contraction-induced activation of the pentose phosphate
pathway and increases IMP production. Second, caffeine stimulates β-oxidation of fatty acyl-CoA,
accompanied by increase in acyl-CoA, butylcarnitine and O-acetylcarnitine; however, it does not
affect the glycolysis metabolites, glycerol-3-phosphate and L-lactic acid. Third, caffeine increases
amino acids levels associated with energy production (L-leucine, L-valine, and L-aspartate). These
metabolic alterations induced by caffeine suggest that caffeine accelerates contraction-induced metabolic
activations and thereby contributes to muscle endurance performance and exercise benefits to health.
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